
|Articles|January 1, 2002
Supplements and Featured Publications
- Symposium Reporter - Lipid Management
- Volume 8
- Issue 1 Symp
Risk Factors Common to Insulin Resistance and Atherosclerosis Explain Why Diabetes is a Cardiovascular Disease
Author(s)Henry N. Ginsberg, MD
Advertisement
Articles in this issue
almost 24 years ago
Review of Clinical trial Data Reaffirms Safety of Statin Therapyalmost 24 years ago
Protective Effects of HDL-C and Need to Raise Low Levels Exploredalmost 24 years ago
Question and Answeralmost 24 years ago
New Cholesterol Guidelines Emphasize Risk AssessmentNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
2
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
3
Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer
4
The Changing Treatment Landscape of IPF and PPF: Toby Maher, MD, PhD
5









